Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana

OBJECTIVES: There are limited data on the prevalence of doravirine (DOR)-associated drug resistance mutations in people with HIV (PWH) in Botswana. This cross-sectional, retrospective study aimed to explore the prevalence of DOR-associated resistance mutations among ART-naïve and -experienced PWH in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bareng, Ontlametse T., Seselamarumo, Sekgabo, Seatla, Kaelo K., Choga, Wonderful T., Bakae, Blessing, Maruapula, Dorcas, Kelentse, Nametso, Moraka, Natasha O., Mokaleng, Baitshepi, Mokgethi, Patrick T., Ditlhako, Tsotlhe R., Pretorius-Holme, Molly, Mbulawa, Mpaphi B., Lebelonyane, Refeletswe, Bile, Ebi Celestin, Gaolathe, Tendani, Shapiro, Roger, Makhema, Joseph M., Lockman, Shahin, Essex, Max, Novitsky, Vlad, Mpoloka, Sununguko W., Moyo, Sikhulile, Gaseitsiwe, Simani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750894/
https://www.ncbi.nlm.nih.gov/pubmed/35973671
http://dx.doi.org/10.1016/j.jgar.2022.08.008

Ejemplares similares

Ejemplares similares